The Future of Weight Loss Medication: What Oral GLP-1s Signal for Treatment Access
November 18, 2025
Important Note: Orforglipron is not yet FDA-approved. This investigational medication is in late-stage trials, with regulatory submission expected in late 2025 and potential [...]